Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.24% | $31.21M | €475.49B | 74.46% | 76 Outperform | |
| Roche Holding AG | 1.34% | $18.68M | CHF294.84B | 46.01% | 73 Outperform | |
| Novartis AG | 1.21% | $16.93M | CHF242.43B | 28.84% | 80 Outperform | |
| AstraZeneca | 1.19% | $16.53M | $323.92B | 30.42% | 80 Outperform | |
| HSBC Holdings | 1.15% | $16.09M | £222.90B | 45.63% | 80 Outperform | |
| Nestlé SA | 1.02% | $14.15M | CHF198.29B | 10.92% | 71 Outperform | |
| Toyota Motor | 0.98% | $13.64M | ¥48.61T | 34.33% | 80 Outperform | |
| Shell (UK) | 0.89% | $12.38M | £165.51B | 11.49% | 73 Outperform | |
| Commonwealth Bank of Australia | 0.84% | $11.76M | AU$295.71B | 18.41% | 64 Neutral | |
| Siemens | 0.83% | $11.56M | €191.01B | 9.25% | 74 Outperform |